Parametric Portfolio Associates’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-33,665
| Closed | -$53K | – | 3683 |
|
2021
Q2 | $53K | Sell |
33,665
-33,320
| -50% | -$52.5K | ﹤0.01% | 3529 |
|
2021
Q1 | $149K | Buy |
66,985
+12,491
| +23% | +$27.8K | ﹤0.01% | 3927 |
|
2020
Q4 | $135K | Buy |
54,494
+13,752
| +34% | +$34.1K | ﹤0.01% | 3852 |
|
2020
Q3 | $100K | Sell |
40,742
-2,482
| -6% | -$6.09K | ﹤0.01% | 3797 |
|
2020
Q2 | $153K | Buy |
43,224
+8,160
| +23% | +$28.9K | ﹤0.01% | 3701 |
|
2020
Q1 | $82K | Sell |
35,064
-1,777
| -5% | -$4.16K | ﹤0.01% | 3759 |
|
2019
Q4 | $81K | Hold |
36,841
| – | – | ﹤0.01% | 3887 |
|
2019
Q3 | $67K | Sell |
36,841
-1,921
| -5% | -$3.49K | ﹤0.01% | 3883 |
|
2019
Q2 | $56K | Sell |
38,762
-20,778
| -35% | -$30K | ﹤0.01% | 3902 |
|
2019
Q1 | $117K | Sell |
59,540
-9,768
| -14% | -$19.2K | ﹤0.01% | 3800 |
|
2018
Q4 | $91K | Sell |
69,308
-39,648
| -36% | -$52.1K | ﹤0.01% | 3791 |
|
2018
Q3 | $268K | Buy |
108,956
+87,057
| +398% | +$214K | ﹤0.01% | 3657 |
|
2018
Q2 | $74K | Buy |
21,899
+8,615
| +65% | +$29.1K | ﹤0.01% | 3828 |
|
2018
Q1 | $56K | Buy |
+13,284
| New | +$56K | ﹤0.01% | 3898 |
|